Palonosetron Injection
Product Images NDC 60505-6193

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Palonosetron (NDC 60505-6193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Palonosetron Hydrochloride (Palonosetron 1)

FDA Label Image

Palonosetron-02 (Palonosetron 2)

FDA Label Image

Palonosetron-03 (Palonosetron 3)

FDA Label Image

Palonosetron-04 (Palonosetron 4)

FDA Label Image

Container Label Ndc 60505-6193-1 (Palonosetron 5)

Container Label Ndc 60505-6193-1 (Palonosetron 5)
This text provides information about a medication with the National Drug Code (NDC) 60505-6193-1 that comes in a 5 mL sterile vial containing 0.25 mg/5 mL (0.05 mg/mL) for intravenous injection only. The medication should be stored at 20°C to 25°C (68°F to 77°F) and protected from light. The manufacturer is Palono_setron Qilu Pharmaceutical based in Haikou, China, and it is manufactured for Apotex Corp. located in Weston, Florida, USA. The LOT number is not visible, and any unused medication in the vial should be discarded. The text also includes information about the expiration date (MM/YYYY) and the company's Global Trade Item Number (GTIN).*
FDA Label Image

Carton Label Ndc 60505-6193-1 (Palonosetron 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.